Periodontitis clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
The Efficacy of Systemic Valacyclovir (Valtrex) on Periodontitis
Sorry, not yet accepting patients
The experiment outlined in this proposal is designed to test the hypothesis that herpesvirus suppression by the systemic anti-herpesvirus valacyclovir (Valtrex) can significantly help to arrest the progressive course of severe marginal periodontitis in adult patients. A prospective, randomized, placebo-controlled, double-blind, clinical trial is employed to test this hypothesis.
San Francisco, California
Our lead scientists for Periodontitis research studies include Mike Sabeti, DDS.
Last updated: